Renal Involvement in Multicentric Castleman Disease With Glomeruloid Hemangioma of Skin and Plasmacytoma

American Journal of Kidney Diseases

Volumn 48, Issue 2, 2006, Pages

  Uthup, Susan ^a   Balachandran, Krishna ^a   Ammal, Vimala Avadai ^a   Abdul Salam, Riyas ^a   George, Jacob ^a   Nair, Geetha M ^a   Leela, Manju ^a  

^a GOVERNMENT MEDICAL COLLEGE   (India)

Author keywords

glomeruloid hemangioma of skin; interleukin 6 (IL 6); membranoproliferative glomerulonephritis; Multicentric Castleman disease; nephrotic syndrome; plasmacytoma; vascular endothelial growth factor (VEGF)

Indexed keywords

CYCLOPHOSPHAMIDE; PREDNISOLONE;

ADULT; ANGIOFOLLICULAR LYMPH NODE HYPERPLASIA; ARTICLE; AXILLARY LYMPH NODE; CASE REPORT; CLINICAL FEATURE; CORTICOSTEROID THERAPY; DIAGNOSTIC APPROACH ROUTE; DIAGNOSTIC TEST; DISEASE COURSE; DRUG WITHDRAWAL; EDEMA; HEPATOMEGALY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYPERGAMMAGLOBULINEMIA; KIDNEY BIOPSY; KIDNEY FAILURE; LYMPH NODE BIOPSY; LYMPHADENOPATHY; MALE; MEDICAL EXAMINATION; MUSCLE WEAKNESS; PLASMACYTOMA; PLEURA EFFUSION; PYREXIA IDIOPATHICA; REMISSION; SKIN BIOPSY; SKIN HEMANGIOMA; THERAPY EFFECT; TISSUE SECTION; TREATMENT OUTCOME; TREATMENT RESPONSE;

BIOPSY; CYCLOPHOSPHAMIDE; GIANT LYMPH NODE HYPERPLASIA; GLOMERULONEPHRITIS, MEMBRANOPROLIFERATIVE; HEMANGIOMA; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; MIDDLE AGED; PLASMACYTOMA; SKIN NEOPLASMS; STEROIDS;

EID: 33745916748     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.ajkd.2006.04.089     Document Type: Article

References (31)

1. McClain K.L., Natkunam Y., and Swerdlow S.H. Atypical cellular disorders. Hematology (2004) 283-296
2. Peterson B.A., and Frizzera G. Multicentric Castleman's disease. Semin Oncol 20 (1993) 636-647
3. Castleman B., Iverson L., and Menendez V.P. Localized mediastinal lymph node hyperplasia resembling thymoma. Cancer 9 (1956) 822-830
4. Herrada J., Cabanillas F., Rice L., Manning J., and Pugh W. Clinical behavior of localized and multicentric Castleman's disease. Ann Intern Med 128 (1998) 657-662
5. Keller A.R., Hocholzer L., and Castleman B. Hyaline-vascular and plasma-cell types of giant lymph node hyperplasia of the mediastinum and other locations. Cancer 29 (1972) 670-683
6. Menegato M.A., Canelles M.F., Tonutti E., and Pizzolitto S. Remission of nephrotic syndrome after thalidomide therapy in a patient with Castleman's disease. Clin Nephrol 61 (2004) 352-356
7. Akimoto H., Shirai M., Usutani S., et al. Membranoproliferative glomerulonephritis-like lesion with fibrillary deposition associated with multicentric Castleman's disease. Nippon Jinzo Gakkai Shi 40 (1998) 301-308
8. Said R., and Tarawneh M. Membranoproliferative glomerulonephritis associated with multicentric angiofollicular lymph node hyperplasia. Case report and review of the literature. Am J Nephrol 12 (1992) 466-470
9. Chan T.M., Cheng I.K., Wong K.L., and Chan K.W. Resolution of membranoproliferative glomerulonephritis complicating angiofollicular lymph node hyperplasia (Castleman's disease). Nephron 65 (1993) 628-632
10. Seida A., Wada J., Morita Y., et al. Multicentric Castleman's disease associated with glomerular microangiopathy and MPGN-like lesion. Does vascular endothelial cell-derived growth factor play causative or protective roles in renal injury?. Am J Kidney Dis 43 1 (2004) E3-E9. http://www.ajkd.org (available www.ajkd.org)
11. Lui S.L., Chan K.W., Li F.K., Cheng I.K., and Chan T.M. Castleman's disease and mesangial proliferative glomerulonephritis. The role of interleukin-6. Nephron 78 (1998) 323-327
12. Leung K.T., Wong K.M., Choi K.S., Chau K.F., and Li C.S. Multicentric Castleman's disease complicated by secondary renal amyloidosis. Nephrology 9 (2004) 392-393
13. Frokjaer Thomsen O., and Ladefoged J. Castleman's disease with renal infiltration by polyclonal plasma cells. Clin Nephrol 49 (1998) 328-330
14. Ruggieri G., Barsotti P., Coppola G., et al. Membranous nephropathy associated with giant lymph node hyperplasia. A case report with histological and ultra structural studies. Am J Nephrol 10 (1990) 323-328
15. Tsukamoto Y., Hanada N., Nomura Y., et al. Rapidly progressive renal failure associated with angiofollicular lymph node hyperplasia. Am J Nephrol 11 (1991) 430-436
16. Yoshizaki K., Matsuda T., Nishimoto N., et al. Pathogenic significance of interleukin-6 (IL-6/BSF-2) in Castleman's disease. Blood 74 (1989) 1360-1367
17. Dupin N., Diss T.L., Kellam P., and Tulliez M. HHV-8 is associated with a plasmablastic variant of Castleman disease that is linked to HHV-8-positive plasmablastic lymphoma. Blood 95 (2000) 1406-1412
18. Parravicini C., Chandran B., Corbellino M., et al. Differential viral protein expression in Kaposi's sarcoma-associated herpesvirus-infected diseases. Kaposi's sarcoma, primary effusion lymphoma, and multicentric Castleman's disease. Am J Pathol 156 (2000) 743-749
19. Aoki Y., Jaffe E.S., Chang Y., et al. Angiogenesis and hematopoiesis induced by Kaposi's sarcoma-associated herpesvirus-encoded interleukin-6. Blood 93 (1999) 4034-4043
20. Chan J.K., Fletcher C.D., Hicklin G.A., and Rosai J. Glomeruloid hemangioma. A distinctive cutaneous lesion of multicentric Castleman's disease associated with POEMS syndrome. Am J Surg Pathol 14 (1990) 1036-1046
21. Velez D., Delgado-Jimenez Y., and Fraga J. Solitary glomeruloid haemangioma without POEMS syndrome. J Cutan Pathol 32 (2005) 449-452
22. Gould S.J., Diss T., and Isaacson P.G. Multicentric Castleman's disease in association with a solitary plasmacytoma. A case report. Histopathology 17 (1990) 135-140
23. Goedert J.J. Multicentric Castleman disease. Viral and cellular targets for intervention. Blood 102 (2003) 2710-2711
24. Bowne W.B., Lewis J.J., Filippa D.A., et al. The management of unicentric and multicentric Castleman's disease. A report of 16 cases and a review of the literature. Cancer 85 (1999) 706-717
25. Corbelling Bestetti M., Scalamogna C., et al. Long term remission of Kaposi sarcoma associated herpes virus related multicentric Castleman's disease with anti Cd-20 monoclonal antibody therapy. Blood 98 (2001) 3473-3475
26. Marcelin A.G., Aaron L., Mateus C., et al. Rituximab therapy for HIV-associated Castleman disease. Blood 102 (2003) 2786-2788
27. Beck J.T., Hsu S.M., Wijdenes J., et al. Alleviation of systemic manifestations of Castleman's disease by monoclonal anti-interleukin-6 antibody. N Engl J Med 330 (1994) 602-605
28. Nishimoto N., Sasai M., Shima Y., et al. Improvement in Castleman's disease by humanized anti-interleukin-6 receptor antibody therapy. Blood 95 (2000) 56-61
29. Atlizumab. Anti-IL-6 receptor antibody-Chugai, anti-interleukin-6 receptor antibody-Chugai, MRA-Chugai. BioDrugs 17 (2003) 369-372
30. Nishimoto N., Kanakura Y., Aozasa K., et al. Humanised anti-interleukin-6 receptor antibody treatment of multicentric Castlemans disease. Blood 106 (2005) 2627-2632
31. Larroche C., Cacoub P., Soulier J., et al. Castleman's disease and lymphoma. Report of eight cases in HIV-negative patients and literature review. Am J Hematol 69 (2002) 119-126